"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...

The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...

Although state officials have promised that blood testing will start in mid-July for people exposed to perflorochemicals, an information meeting about the testing process won’t take place until July ...

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...

Pituitary tumors are atypical growths that develop in the pituitary gland. They are typically noncancerous. Doctors often use blood tests as a first step in diagnosing pituitary tumors. The pituitary ...

A blood osmolality test measures the blood for the concentration of certain dissolved particles. This test can show whether a person has an irregular balance of fluids in their body. Osmolality tests ...

FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Babson Diagnostics, a science-first ...

A San Diego company has earned FDA clearance for a device that could make blood testing easier. Truvian Health’s device, TruVerus, uses a small amount of blood to return routine tests quickly. The ...

Becton, Dickinson and Company BDX, popularly known as BD, and Babson Diagnostics announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other ...